Geneva Advisors’s ResMed RMD Stock Holding History

Geneva Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$393K	Hold	5,050	–	–	0.01%	556
2017 Q1	$363K	Sell	5,050 -51	-1%	-$3.52K	0.01%	563
2016 Q4	$317K	Buy	5,101 +51	+1%	+$3.12K	0.01%	568
2016 Q3	$327K	Hold	5,050	–	–	0.01%	557
2016 Q2	$319K	Hold	5,050	–	–	0.01%	541
2016 Q1	$292K	Hold	5,050	–	–	0.01%	544
2015 Q4	$271K	Hold	5,050	–	–	0.01%	524
2015 Q3	$257K	Sell	5,050 -3,000	-37%	-$161K	0.01%	515
2015 Q2	$454K	Hold	8,050	–	–	0.01%	439
2015 Q1	$578K	Hold	8,050	–	–	0.01%	389
2014 Q4	$451K	Buy	8,050 +2,795	+53%	+$146K	0.01%	429
2014 Q3	$259K	Sell	5,255 -950	-15%	-$48.4K	﹤0.01%	545
2014 Q2	$314K	Hold	6,205	–	–	0.01%	509
2014 Q1	$277K	Sell	6,205 -3,000	-33%	-$135K	0.01%	496
2013 Q4	$433K	Hold	9,205	–	–	0.01%	355
2013 Q3	$486K	Sell	9,205 -600	-6%	-$29.1K	0.01%	339
2013 Q2	$442K	Buy	+9,805	New	+$465K	0.01%	296

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Geneva Advisors's RMD Position: Q2 2017 in Review

Geneva Advisors held its ResMed (RMD) position steady in Q2 2017 at 5,050 shares worth $393K. The position accounts for 0.01% of the portfolio, ranked #556.

Geneva Advisors first reported a position in RMD in Q2 2013 and has held it in 17 quarters since. The position peaked at $578K in Q1 2015. 340 funds tracked by Wall St. Rank hold RMD as of Q2 2017.

Geneva Advisors held 5,050 shares of ResMed worth $393K as of Q2 2017.
Geneva Advisors left its ResMed share count unchanged in Q2 2017.
ResMed made up 0.01% of Geneva Advisors's portfolio in Q2 2017, its #556 holding.
Geneva Advisors first reported a position in ResMed in Q2 2013 and has held it in 17 quarters since.
Geneva Advisors's ResMed position peaked at $578K in Q1 2015.
340 funds tracked by Wall St. Rank held ResMed as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.